Recent Advances in the Development of Anti-Infective Prophylactic and/or Therapeutic Agents Based on Toll-Like Receptor (TLRs)

Author(s): Elena C. Junquera, Lourdes Mateos-Hernández, Jose de la Fuente, Jose M.P. de la Lastra

Journal Name: Recent Patents on Anti-Infective Drug Discovery
Continued as Recent Advances in Anti-Infective Drug Discovery

Volume 9 , Issue 1 , 2014

Become EABM
Become Reviewer
Call for Editor


Toll-like receptors (TLRs) are key players in innate immunity. They are able to sense different microorganisms ranging from protozoa to bacteria, fungi or viruses. Innate immune responses can directly influence adaptive immune responses. Therefore, TLRs are considered as relevant targets for therapeutic applications in immune diseases: such as autoimmune disorders, allergy, sepsis, and cancer. We here review the recent patents based on the modulation of the toll-like receptors to develop anti-infective (prophylactic and/or therapeutic) agents.

Keywords: Agonist, antagonist, anti-infective agents, immune therapy, innate immunity, toll-like receptors, vaccine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 16 June, 2014
Page: [14 - 24]
Pages: 11
DOI: 10.2174/1574891X09666140616164918

Article Metrics

PDF: 39